Amedisys Inc (AMED)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Amedisys Inc (AMED) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8012221
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月14日
◆ページ数:35
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Amedisys Inc (Amedisys) is a healthcare company that offers home health care, hospice service and personal care. The company provides practical nursing services and occupational therapy, comfort and support services for those are facing a terminal illness. It also provides speech pathology, social services for acute and chronic illnesses, private duty services and home health aide services. The company operates a network of medicare-certified home health care centers, and medicare-certified hospice care centers which cover across several states in the US and the District of Columbia. Amedisys is headquartered in Baton Rouge, Louisiana, the US.

Amedisys Inc (AMED) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Amedisys Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Amedisys Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Amedisys Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Amedisys Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 8
Amedisys Inc, Pharmaceuticals & Healthcare, Deal Details 9
Asset Purchase 9
Amedisys Completes Acquisition Of Hospice Of Hackensack University Medical Center For US$4 Million 9
Asset Transactions 11
Amedisys Plans To Divest 35 Care Centers 11
Acquisition 12
Amedisys Completes The Acquisition Of Beacon Hospice 12
Amedisys Inc – Key Competitors 13
Amedisys Inc – Key Employees 14
Amedisys Inc – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Joint Venture 18
Recent Developments 20
Financial Announcements 20
Nov 07, 2017: Amedisys Reports Third Quarter 2017 Financial Results 20
Oct 24, 2017: Amedisys Previews Strong Third Quarter 2017 Results 21
Jul 26, 2017: Amedisys Reports Second Quarter 2017 Financial Results 22
May 02, 2017: Amedisys Reports First Quarter 2017 Financial Results 23
Feb 28, 2017: Amedisys Reports Fourth Quarter and Year End 2016 Financial Results 24
Nov 03, 2016: Amedisys Reports Third Quarter Financial Results 25
Aug 02, 2016: Amedisys Reports Second Quarter Financial Results 26
May 03, 2016: Amedisys Reports First Quarter Financial Results 27
Mar 08, 2016: Amedisys Reports Fourth Quarter and Year End Financial Results 28
Corporate Communications 29
Oct 06, 2017: Scott Ginn Promoted to Chief Financial Officer at Amedisys 29
Jan 30, 2017: Amedisys Welcomes David Mikula as Chief Development Officer 30
Dec 20, 2016: Amedisys Welcomes Gary D. Willis as New Chief Financial Officer 31
Nov 04, 2016: Amedisys Brings In Christopher Gerard As New Chief Operating Officer 32
Apr 26, 2016: Amedisys Welcomes Three New Members To Its Board Of Directors 33
Other Significant Developments 34
Aug 17, 2017: Amedisys Clinical Programs Team Achieves National Readmissions Prevention Collaborative Certification 34
Appendix 35
Methodology 35
About GlobalData 35
Contact Us 35
Disclaimer 35

List of Tables
Amedisys Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Amedisys Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 2
Amedisys Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Amedisys Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Amedisys Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Amedisys Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 8
Amedisys Completes Acquisition Of Hospice Of Hackensack University Medical Center For US$4 Million 9
Amedisys Plans To Divest 35 Care Centers 11
Amedisys Completes The Acquisition Of Beacon Hospice 12
Amedisys Inc, Key Competitors 13
Amedisys Inc, Key Employees 14
Amedisys Inc, Subsidiaries 15
Amedisys Inc, Joint Venture 18

★海外企業調査レポート[Amedisys Inc (AMED)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Enerplus Corp Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Enerplus Corp Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Enerplus Corp (Enerplus), formerly Enerplus Resources Fund is an oil and gas company that offers exploration and development services. The company provides exploration and development of natural resour …
  • Carlisle Coatings & Waterproofing Inc:企業の戦略的SWOT分析
    Carlisle Coatings & Waterproofing Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and maj …
  • Enel Generacion Chile SA:企業の発電所・SWOT分析2018
    Enel Generacion Chile SA - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key empl …
  • Hung Hing Printing Group Limited:企業の戦略・SWOT・財務情報
    Hung Hing Printing Group Limited - Strategy, SWOT and Corporate Finance Report Summary Hung Hing Printing Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Advanced BioScience Laboratories Inc-製薬・医療分野:企業M&A・提携分析
    Summary Advanced BioScience Laboratories Inc (ABL), a subsidiary of Institut Merieux SA is a contract research and manufacturing company that provides services to life sciences industry. The company develops vaccines, therapeutics and other biologic products. It provides proof-of-concept in vivo stu …
  • SINTX Technologies Inc (SINT)
    SINTX Technologies Inc (SINT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • Alere Toxicology Plc:企業の戦略的SWOT分析
    Alere Toxicology Plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Dean Foods Co:戦略・SWOT・企業財務分析
    Dean Foods Co - Strategy, SWOT and Corporate Finance Report Summary Dean Foods Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Therabron Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Therabron Therapeutics Inc (Therabron), formerly Clarassance Inc is a clinical-stage biopharmaceutical company that develops drugs based on secretoglobin family of proteins. The company’s lead biopharmaceutical candidate includes CG100, CG201, CG367, CG459 and CG1011. Its CC10 protein candid …
  • Nevro Corp (NVRO):企業の財務・戦略的SWOT分析
    Nevro Corp (NVRO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Maxion Wheels Inc:企業の戦略的SWOT分析
    Maxion Wheels Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Accelya Kale Solutions Limited (ACCELYA):企業の財務・戦略的SWOT分析
    Accelya Kale Solutions Limited (ACCELYA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Concert Pharmaceuticals Inc (CNCE):製薬・医療:M&Aディール及び事業提携情報
    Summary Concert Pharmaceuticals Inc (Concert Pharmaceuticals) is a clinical stage biotechnology company which discovers and develops small molecule drugs. The company develops its products using its deuterated chemical entity (DCE) platform to develop novel therapeutics for autoimmune and inflammato …
  • T-Mobile US Inc (TMUS):企業の財務・戦略的SWOT分析
    T-Mobile US Inc (TMUS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Antiva Biosciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Antiva Biosciences Inc (Antiva) formerly Hera Therapeutics Inc, is a clinical stage bio-pharmaceutical company focused on the development of novel medicines for the treatment of diseases caused by human papillomavirus (HPV) infection. Its lead product candidate ABI-1968, is a double prodrug …
  • Honkarakenne Oyj (HONBS):企業の財務・戦略的SWOT分析
    Honkarakenne Oyj (HONBS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Regenicin Inc (RGIN):企業の財務・戦略的SWOT分析
    Summary Regenicin Inc (Regenicin), formerly Windstar Inc is a biotechnology company that develops regenerative cell therapies. The company offers NovaDerm, a tissue-engineered skin prepared from autologous skin cells. Its NovaDerm technology uses the patient’s own skin cells to generate living, tiss …
  • Williams-Sonoma, Inc.:戦略・SWOT・企業財務分析
    Williams-Sonoma, Inc. - Strategy, SWOT and Corporate Finance Report Summary Williams-Sonoma, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • International SOS Pte Ltd:企業の戦略的SWOT分析
    International SOS Pte Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Reliance Naval and Engineering Ltd:企業のM&A・事業提携・投資動向
    Reliance Naval and Engineering Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Reliance Naval and Engineering Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on m …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆